mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.11 |
0.7 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |